Home/Filings/4/0001493152-22-023376
4//SEC Filing

Carter Jennifer L. 4

Accession 0001493152-22-023376

CIK 0001642380other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 8:17 PM ET

Size

8.9 KB

Accession

0001493152-22-023376

Insider Transaction Report

Form 4
Period: 2022-08-15
Transactions
  • Award

    Option to Purchase Common Stock

    2022-08-15+45,00045,000 total
    Exercise: $0.97Exp: 2032-08-15Common Stock (45,000 underlying)
  • Award

    Common Stock, no par value

    2022-08-15+10,00020,000 total
  • Purchase

    Common Stock, no par value

    2022-08-16$0.95/sh+10,500$9,97530,500 total
Footnotes (2)
  • [F1]The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
  • [F2]Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.

Documents

1 file

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother

Related Parties

1
  • filerCIK 0001806505

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 8:17 PM ET
Size
8.9 KB